Target intelligence / Profile preview

Interleukin-10 receptor complex (IL-10R)

Target
IL-10R
Molecular classification
Receptor, Type II cytokine receptor
01

Overview

The interleukin-10 (IL-10) receptor complex is a cell-surface heterotetrameric receptor composed of two ligand-binding alpha subunits (IL-10RA) and two accessory beta subunits (IL-10RB). Primarily expressed on hematopoietic cells, this type II cytokine receptor complex plays a critical role in maintaining immune homeostasis and limiting inflammatory tissue damage. Upon binding of the homodimeric IL-10 cytokine, the receptor complex undergoes a conformational change that activates constitutively associated Janus kinases (JAK1 and TYK2), leading to the phosphorylation and nuclear translocation of STAT3. This signaling cascade suppresses the transcription of pro-inflammatory cytokines (such as TNF-alpha, IL-1, and IL-6) in myeloid cells, while paradoxically promoting the survival, proliferation, and cytotoxic activity of CD8+ T cells and natural killer (NK) cells in specific contexts.

In clinical pathology, genetic deficiencies or mutations in IL-10RA or IL-10RB lead to severe, early-onset inflammatory bowel disease (VEO-IBD) due to uninhibited intestinal inflammation. Conversely, overexpression of the IL-10 pathway in the tumor microenvironment can facilitate tumor immune evasion by suppressing dendritic cell maturation and antigen presentation. Therapeutic strategies targeting this receptor complex are dual-natured: long-acting agonists, such as pegilodecakin, and gene therapies, like XT-150, are developed to either stimulate anti-tumor immunity in oncology or restore immune tolerance in chronic inflammatory conditions. Meanwhile, receptor-blocking monoclonal antibodies are being investigated to alleviate immunosuppression in cancer and chronic infections, though managing the risk of autoimmune-like toxicities and hematological side effects remains a key therapeutic challenge.

Other names
IL10RA/IL10RB receptor complexInterleukin-10 receptorIL-10 receptorIL10RIL-10R complexCD210
02

Mechanism of action

Agonism of the receptor complex activates the JAK1/TYK2-STAT3 pathway to suppress pro-inflammatory cytokines or stimulate cytotoxic T-cell activity, while antagonism blocks immunosuppressive signaling to enhance anti-tumor immunity.

03

Biological functions

Signal transductionImmune responseInflammatory responseCell survivalCell proliferation
04

Disease associations

CancerInflammationAutoimmune diseaseInfection
05

Safety considerations

Hematological toxicities such as anemia and thrombocytopeniaCytokine release syndrome or systemic inflammationSevere colitis or very early-onset inflammatory bowel disease (VEO-IBD) if the pathway is completely blocked or deficientNarrow therapeutic windowImmune-related adverse events (irAEs) such as excessive inflammation or autoimmune-like reactions when blocking the receptor
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

STAT3 phosphorylation (p-STAT3)Interferon-gamma (IFN-g) levelsIL-10 expression levelsCD8+ T-cell infiltrationGranzyme B levels

Beyond the preview

Go deeper on Interleukin-10 receptor complex (IL-10R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-10 receptor complex (IL-10R).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call